The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[6-(3-methylpyridin-2-yl)-2-(pyridin-3-yl)-1,2,3,4-tetrahydroquinoline-1-carbonyl]benzene-1,3-diol ID: ALA3719351
PubChem CID: 117967774
Max Phase: Preclinical
Molecular Formula: C27H23N3O3
Molecular Weight: 437.50
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccnc1-c1ccc2c(c1)CCC(c1cccnc1)N2C(=O)c1ccc(O)cc1O
Standard InChI: InChI=1S/C27H23N3O3/c1-17-4-2-13-29-26(17)19-7-11-23-18(14-19)6-10-24(20-5-3-12-28-16-20)30(23)27(33)22-9-8-21(31)15-25(22)32/h2-5,7-9,11-16,24,31-32H,6,10H2,1H3
Standard InChI Key: XWHRRPRMSJTOHZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
-2.5954 -5.2538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2959 -6.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0027 -5.2521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0018 -3.7520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2978 -3.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5964 -3.7538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0423 -5.8514 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6342 -5.8545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2995 -2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3402 -3.5957 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8926 -1.4990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1929 -0.7510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4908 -1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4885 -3.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1883 -3.7510 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8904 -2.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8985 3.0030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1925 3.7616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4965 3.0203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5065 1.5203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2125 0.7617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2206 -0.4383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
1 8 1 0
4 9 1 0
9 17 1 0
9 10 2 0
15 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 16 1 0
15 16 2 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
18 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
12 27 1 0
32 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.50Molecular Weight (Monoisotopic): 437.1739AlogP: 5.20#Rotatable Bonds: 3Polar Surface Area: 86.55Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.82CX Basic pKa: 5.16CX LogP: 4.70CX LogD: 4.56Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.46Np Likeness Score: -0.52
References 1. (2015) Tetrahydroisoquinoline compounds and their use as pyruvate dehydrogenase kinase inhibitors, 2. Morrell, J A JA and 5 more authors. 2003-12 AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2. [PMID:14641019 ] 3. Moore, Jonathan D and 12 more authors. 2014-12-30 VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells. [PMID:25404640 ] 4. Tso, Shih-Chia and 9 more authors. 2017-02-09 Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors. [PMID:28085286 ]